We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
NorthWestern Energy
NWE
$4.45B
| $1.47M | ﹤0.01% |
+28,843
| New | +$1.41M |
|
1477
VEON
VEON
$3.57B
| $1.46M | ﹤0.01% |
61,001
-3,759
| -6% | -$83.7K |
|
1478
PUT
TSMC
TSM
$2.03T
| $1.46M | ﹤0.01% |
9,600
+2,400
| +33% | +$298K |
|
|
SPNS
1479
DELISTED
Sapiens International
SPNS
| $1.45M | ﹤0.01% |
45,213
-91,128
| -67% | -$2.64M |
|
1480
Theravance Biopharma
TBPH
$875M
| $1.45M | ﹤0.01% |
+162,073
| New | +$1.5M |
|
1481
Gossamer Bio
GOSS
$100M
| $1.45M | ﹤0.01% |
1,231,745
+215,962
| +21% | +$238K |
|
|
WKME
1482
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $1.45M | ﹤0.01% |
168,366
-5,256
| -3% | -$51.2K |
|
|
CFLT
1483
DELISTED
Confluent
CFLT
| $1.45M | ﹤0.01% |
47,393
-615,712
| -93% | -$17.4M |
|
1484
World Kinect Corp
WKC
$2.06B
| $1.45M | ﹤0.01% |
54,674
+30,074
| +122% | +$714K |
|
1485
Thermo Fisher Scientific
TMO
$214B
| $1.44M | ﹤0.01% |
2,481
-420,095
| -99% | -$236M |
|
1486
PRA Group
PRAA
$688M
| $1.44M | ﹤0.01% |
+55,106
| New | +$1.34M |
|
1487
Dream Finders Homes
DFH
$1.49B
| $1.43M | ﹤0.01% |
+32,812
| New | +$1.16M |
|
|
RNWWW
1488
CALL
ReNew Energy Global PLC Warrant
RNWWW
$63K
| $1.43M | ﹤0.01% |
236,802
-8,796
| -4% | -$5.92K |
|
1489
Sphere Entertainment
SPHR
$5.06B
| $1.43M | ﹤0.01% |
29,125
+7,541
| +35% | +$302K |
|
1490
Digimarc Corp
DMRC
$145M
| $1.42M | ﹤0.01% |
52,391
+36,412
| +228% | +$1.26M |
|
1491
KBR
KBR
$4.74B
| $1.42M | ﹤0.01% |
+22,348
| New | +$1.27M |
|
1492
Fastenal
FAST
$55.2B
| $1.42M | ﹤0.01% |
36,816
-2,636
| -7% | -$93.2K |
|
1493
Southwest Gas
SWX
$6.7B
| $1.42M | ﹤0.01% |
18,638
-1,892
| -9% | -$123K |
|
1494
Marriott International
MAR
$101B
| $1.42M | ﹤0.01% |
+5,618
| New | +$1.36M |
|
1495
Zentalis Pharmaceuticals
ZNTL
$329M
| $1.4M | ﹤0.01% |
89,012
| – | – |
|
|
XFINW
1496
CALL
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
| $1.4M | ﹤0.01% |
126,266
| – | – |
|
1497
NCR Atleos
NATL
$3.47B
| $1.4M | ﹤0.01% |
+70,957
| New | +$1.52M |
|
1498
Agilon Health
AGL
$1.65B
| $1.39M | ﹤0.01% |
+9,119
| New | +$1.52M |
|
|
AUGX
1499
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.38M | ﹤0.01% |
338,445
+294,720
| +674% | +$1.32M |
|
1500
Viridian Therapeutics
VRDN
$2.15B
| $1.38M | ﹤0.01% |
78,701
-222,588
| -74% | -$4.32M |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.